M Vilches1, A Nieto2. 1. Unidad de Investigación, Hospital Universitario Puerta del Mar, Cádiz, Spain. 2. UGC de Hematología e Inmunología, Hospital Universitario Puerta del Mar, Cádiz, Spain. Electronic address: antonioj.nieto.sspa@juntadeandalucia.es.
Abstract
BACKGROUND: The impact of pregnancy on the incidence of HLA sensitization is poorly explored, and most of the data were obtained by use of a complement-dependent cytotoxicity (CDC) assay with an incidence of 18% to 30%. In many cases, antibodies cannot be detected by CDC as their level fades in time. However, this state of "latent" sensitization can still have a significant clinical impact in a subsequent transplantation setting. METHODS: Pregnancy-induced HLA sensitization was analyzed in 69 mothers without a history of transfusions or transplants. The mothers and their offspring were typed for HLA-A, HLA-B, and HLA-DR. Sera from the mothers were studied using the Luminex screening test to detect anti-HLA class I and class II antibodies. Positive and borderline sera were further analyzed using single antigen kits. RESULTS: Thirty-four sera (49.3%) were positive in the screening test (52.9% for class I and 61.7% for class II antibodies). All of them tested positive for paternal alloantigens by single antigen. Positive paternal alloantigens were also detected in 52.9% of class I and 36.3% of class II sera with borderline screening. Interestingly, in a further analysis, the mean of the MFIs of paternal alloantigens that resulted negative was calculated and compared with that of neutral alloantigens and that of maternal self-antigens; in both cases, differences were highly significant (288 vs 153, P < .0001; 288 vs 102, P < .0001; respectively). CONCLUSIONS: This study shows a high incidence of pregnancy-induced HLA sensitization and suggests that HLA typing of partners of women who have been pregnant may contribute to a better risk assessment in the transplantation setting.
BACKGROUND: The impact of pregnancy on the incidence of HLA sensitization is poorly explored, and most of the data were obtained by use of a complement-dependent cytotoxicity (CDC) assay with an incidence of 18% to 30%. In many cases, antibodies cannot be detected by CDC as their level fades in time. However, this state of "latent" sensitization can still have a significant clinical impact in a subsequent transplantation setting. METHODS: Pregnancy-induced HLA sensitization was analyzed in 69 mothers without a history of transfusions or transplants. The mothers and their offspring were typed for HLA-A, HLA-B, and HLA-DR. Sera from the mothers were studied using the Luminex screening test to detect anti-HLA class I and class II antibodies. Positive and borderline sera were further analyzed using single antigen kits. RESULTS: Thirty-four sera (49.3%) were positive in the screening test (52.9% for class I and 61.7% for class II antibodies). All of them tested positive for paternal alloantigens by single antigen. Positive paternal alloantigens were also detected in 52.9% of class I and 36.3% of class II sera with borderline screening. Interestingly, in a further analysis, the mean of the MFIs of paternal alloantigens that resulted negative was calculated and compared with that of neutral alloantigens and that of maternal self-antigens; in both cases, differences were highly significant (288 vs 153, P < .0001; 288 vs 102, P < .0001; respectively). CONCLUSIONS: This study shows a high incidence of pregnancy-induced HLA sensitization and suggests that HLA typing of partners of women who have been pregnant may contribute to a better risk assessment in the transplantation setting.
Authors: Ashley N Suah; Dong-Kha V Tran; Stella Hw Khiew; Michael S Andrade; Jared M Pollard; Dharmendra Jain; James S Young; Dengping Yin; Geetha Chalasani; Maria-Luisa Alegre; Anita S Chong Journal: J Clin Invest Date: 2021-01-04 Impact factor: 14.808
Authors: Jacqueline N Poston; Arijita Jash; Lindsay M Hannan; Ariel M Hay; Chomkan Usaneerungrueng; Heather L Howie; Linda M Kapp; James C Zimring Journal: Transfusion Date: 2020-12-18 Impact factor: 3.337
Authors: Dae Hyun Ko; Hyun Soo Kim; Jungwon Hyun; Han Sung Kim; Jae Seok Kim; Kyoung Un Park; Wonkeun Song Journal: Ann Lab Med Date: 2017-09 Impact factor: 3.464